Abbott Laboratories (ABT) on Tuesday said it received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next-generation Ultreon 3.0 AI-powered coronary imaging platform.
The system uses optical coherence tomography (OCT) to provide real-time guidance to doctors during minimally invasive procedures to open blocked heart arteries.
Abbott shares closed at $92.80 on Monday, up 1.83%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.